Delray Medical Center cut the ribbon on its newest high-tech machine that targets brain areas to treat movement disorders ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...

A 47-year-old man was the first in the world to be treated outside of a study context with a new technique for the symptoms ...

Learn how caffeine affects Parkinson's disease prevention and treatment. New research uncovers both protective benefits and treatment limitations.

In the past, Parkinson’s disease was primarily considered a disorder of the nervous system, centered in the brain. However, ...

Parkinson's disease is a solvable problem, but only if we act decisively and urgently. We have the knowledge, and we've built ...

A new discovery in blood immune cells has put researchers one step closer to identifying a blood biomarker that would allow ...

University of Arizona researchers revealed that dyskinesia in Parkinson’s patients stems from a disconnect in the motor ...

Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's drug levodopa.

The US company has said it is launching the Phase III trials in the first half of this year after Phase I talks with the US ...

A transformative $5 million gift from Jean-Pierre Conte to UCSF to established two endowed professorships in the Department ...